MedPath

Otsuka Canada Pharmaceutical Inc.

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Aripiprazole Once-Monthly in Hospitalized Patients (INITIATE)

Conditions
Bipolar I Disorder
Schizophrenia
Schizo Affective Disorder
First Posted Date
2021-05-28
Last Posted Date
2022-04-20
Lead Sponsor
Otsuka Canada Pharmaceutical Inc.
Target Recruit Count
200
Registration Number
NCT04907279
Locations
🇨🇦

Ottawa Hospital, Civic Campus, Ottawa, Ontario, Canada

Canadian Medical Assessment of JINARC™ Outcomes Registry

Recruiting
Conditions
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
First Posted Date
2016-10-05
Last Posted Date
2025-07-30
Lead Sponsor
Otsuka Canada Pharmaceutical Inc.
Target Recruit Count
530
Registration Number
NCT02925221

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.